Novo Nordisk (Denmark)

8.9k papers and 387.2k indexed citations i.

About

In recent decades, authors affiliated with Novo Nordisk (Denmark) have published 8.9k papers, which have received a total of 387.2k indexed citations. Scholars at this organization have produced 2.7k papers in Molecular Biology, 2.3k papers in Endocrinology, Diabetes and Metabolism and 1.2k papers in Surgery on the topics of Diabetes Treatment and Management (1.4k papers), Diabetes Management and Research (1.2k papers) and Pancreatic Islet Dysfunction and Regeneration (862 papers). Their work is cited by papers focused on Molecular Biology (115.5k citations), Endocrinology, Diabetes and Metabolism (101.0k citations) and Surgery (57.2k citations). Authors at Novo Nordisk (Denmark) collaborate with scholars in Denmark, United States and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Novo Nordisk (Denmark)'s most productive authors include Jens J. Holst, Lotte Bjerre Knudsen, John B. Buse, Lars Thim and C. J. Pethick.

In The Last Decade

Fields of papers published by authors at Novo Nordisk (Denmark)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Novo Nordisk (Denmark) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Novo Nordisk (Denmark)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novo Nordisk (Denmark). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novo Nordisk (Denmark) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novo Nordisk (Denmark) more than expected).

Rankless by CCL
2025